Short Duration Treatment of Non-severe Community Acquired Pneumonia
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when
compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of
treatment in terms of clinical efficacy, in adults admitted to emergency services for a non
severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin
treatment (3GC or A/AC).